MoneyWorks4Me

The company witnessed a 12.23% growth in the revenue at Rs. 25780.00 millions for the quarter ended December 2025 as compared to Rs. 22970.00 millions during the year-ago period.Profit after tax improved marginally to Rs. 5980.00  millions for the quarter ended December 2025 from Rs. 5940.00 millions of corresponding previous quarter.OP of the company witnessed a marginal growth to 9940.00 millions from 8290.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 25780.00 22970.00 12.23 75950.00 66620.00 14.00 91980.00 76650.00 20.00
Other Income 870.00 820.00 6.10 3520.00 2660.00 32.33 3520.00 3370.00 4.45
PBIDT 9940.00 8290.00 19.90 28970.00 23630.00 22.60 33310.00 25110.00 32.66
Interest 60.00 0.00 0.00 170.00 10.00 1600.00 10.00 30.00 -66.67
PBDT 9140.00 8290.00 10.25 28060.00 23620.00 18.80 33300.00 25080.00 32.78
Depreciation 1160.00 990.00 17.17 3410.00 2940.00 15.99 4010.00 3760.00 6.65
PBT 7980.00 7300.00 9.32 24650.00 20680.00 19.20 29290.00 21320.00 37.38
TAX 2000.00 1360.00 47.06 6140.00 5260.00 16.73 7200.00 5560.00 29.50
Deferred Tax -80.00 -360.00 -77.78 -50.00 -420.00 -88.10 -730.00 450.00 -262.22
PAT 5980.00 5940.00 0.67 18510.00 15420.00 20.04 22090.00 15760.00 40.16
Equity 530.00 530.00 0.00 530.00 530.00 0.00 530.00 530.00 0.00
PBIDTM(%) 38.56 36.09 6.83 38.14 35.47 7.54 36.21 32.76 10.55
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..